Who is sponsoring NCT04758715?

NCT04758715 is sponsored by University of Nebraska Lincoln.

What drugs are being tested in NCT04758715?

Interventions in NCT04758715: Food provided from a commercial meal service provider for a week.

What condition does NCT04758715 study?

NCT04758715 studies Microbiome, Human, Gastrointestinal Tract.

Is NCT04758715 still recruiting?

NCT04758715 is currently active, enrolled. Last updated 21 October 2024.

Last reviewed 2024-10-21 · How we verify

NCT04758715

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Diet and Microbiome Longitudinal Monitoring With Food Intervention

Active, enrolled NA Last updated 21 October 2024

What this trial tests

NA trial testing Food provided from a commercial meal service provider for a week in Microbiome, Human in 65 participants. Participants enrolled and being followed up; not accepting new ones.

Timeline

2 February 2021

Primary endpoint
28 February 2030

28 February 2030

Quick facts

Lead sponsor	University of Nebraska Lincoln
Phase	NA
Status	Active, enrolled
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	basic science
Enrollment	65
Start date	2 February 2021
Primary completion	28 February 2030
Estimated completion	28 February 2030
Sites	1 location across United States

Drugs / interventions tested

Food provided from a commercial meal service provider for a week

Conditions studied

Microbiome, Human — all drugs for Microbiome, Human →
Gastrointestinal Tract — all drugs for Gastrointestinal Tract →

Sponsor

University of Nebraska Lincoln

Who can join

19 and older, any sex, with Microbiome, Human or Gastrointestinal Tract. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The main goal of this project is to identify the microbiome components change in abundance in response to food ingested including provided foods.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Microbiome, Human

Currently open trials in the same condition.

NCT07316465 — Birth Cohort: Development of IgE Autoantibodies in Newborns With (High Risk of) Atopic Dermatitis · NA · recruiting

Other University of Nebraska Lincoln trials

Trials by the same sponsor.

NCT07160530 — Healthy Children, Healthy Communities: Effectiveness of a Multilevel Rural Community Engagement Model for Improving Chil · NA · recruiting
NCT06935435 — Effects of Distinct Nebraska-Dry Bean Market Classes on Gut Microbiota · NA · active not recruiting
NCT05873413 — Motivations, Attitudes, and Perceptions Study · NA · recruiting
NCT05988398 — Preventing Commercial Sexual Exploitation of Children · NA · completed
NCT05791825 — Evaluation of the CHIME Intervention for Improving Early Head Start/Head Start Educator Well-being · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04758715 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Nebraska Lincoln
Last refreshed: 21 October 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04758715.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing